| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $8.4B | — | — | — | — |
| Op. Income | $2.1B | — | — | — | — |
| Gross Margin | 33.4% | — | — | — | — |
| Net Margin | 8.6% | — | — | — | — |
| EPS (Diluted) | $0.35 | — | — | — | — |
| Free Cash Flow | $1.1B | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $8.4B |
| Cost of Revenue | $5.6B |
| GROSS PROFIT | $2.8B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $687M |
| SG&A Expenses | $687M |
| Other Expenses | $51M |
| Operating Expenses | $739M |
| Cost & Expenses | $6.3B |
| OPERATING INCOME | $2.1B |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | -$521M |
| INCOME BEFORE TAX | $1.5B |
| Income Tax Expense | $479M |
| Net Income from Continuing Ops | $1.1B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $718M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $718M |
| D&A | $1.1B |
| EBIT | $2.1B |
| EBITDA | $3.2B |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $8.4B |
| Cost of Revenue | $5.6B |
| GROSS PROFIT | $2.8B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $687M |
| SG&A Expenses | $687M |
| Other Expenses | $51M |
| Operating Expenses | $739M |
| Cost & Expenses | $6.3B |
| OPERATING INCOME | $2.1B |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | -$521M |
| INCOME BEFORE TAX | $1.5B |
| Income Tax Expense | $479M |
| Net Income from Continuing Ops | $1.1B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $718M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $718M |
| D&A | $1.1B |
| EBIT | $2.1B |
| EBITDA | $3.2B |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $718M |
| Depreciation & Amortization | $1.1B |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $479M |
| Other Non-Cash Items | $486M |
| Change in Working Capital | -$336M |
| OPERATING CASH FLOW | $2.5B |
| Capital Expenditure | -$1.4B |
| Acquisitions (Net) | -$18M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $530M |
| NET CASH FROM INVESTING | -$876M |
| Net Debt Issuance | -$661M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$92M |
| Other Financing Activities | -$701M |
| NET CASH FROM FINANCING | -$1.5B |
| FREE CASH FLOW | $1.1B |
| Net Change in Cash | $69M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $2.9B |
| Short-Term Investments | $945M |
| Net Receivables | $8.8B |
| Inventory | $3.0B |
| Other Current Assets | $1.1B |
| TOTAL CURRENT ASSETS | $16.8B |
| PP&E (Net) | $42.6B |
| Goodwill | $1.8B |
| Intangible Assets | $4.1B |
| Long-Term Investments | $3.3B |
| Tax Assets | $3.4B |
| Other Non-Current Assets | $9.8B |
| TOTAL NON-CURRENT ASSETS | $65.1B |
| TOTAL ASSETS | $81.8B |
| Account Payables | $5.1B |
| Short-Term Debt | $3.5B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $1.2B |
| TOTAL CURRENT LIABILITIES | $11.0B |
| Long-Term Debt | $28.5B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $12.3B |
| TOTAL NON-CURRENT LIABILITIES | $40.9B |
| TOTAL LIABILITIES | $51.8B |
| Common Stock | $7.0B |
| Additional Paid-In Capital | $1.9B |
| Retained Earnings | $11.0B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $2.8B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $22.6B |
| Minority Interest | $7.4B |
| TOTAL EQUITY | $30.0B |
| TOTAL LIABILITIES & EQUITY | $81.8B |
| Total Debt | $32.0B |
| Net Debt | $29.1B |
